ASH 2022 Conference Coverage
ASH 2022 Phase 1/2 Results From MonumenTAL-1: Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D x CD3 Bispecific Antibody, in R/R MM
By
ASH 2022 Conference Coverage
FEATURING
Ajai Chari
By
ASH 2022 Conference Coverage
FEATURING
Ajai Chari
Login to view comments.
Click here to Login